全文获取类型
收费全文 | 17960篇 |
免费 | 2036篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 336篇 |
儿科学 | 405篇 |
妇产科学 | 511篇 |
基础医学 | 2169篇 |
口腔科学 | 460篇 |
临床医学 | 1739篇 |
内科学 | 3158篇 |
皮肤病学 | 265篇 |
神经病学 | 1303篇 |
特种医学 | 693篇 |
外国民族医学 | 2篇 |
外科学 | 4462篇 |
综合类 | 208篇 |
一般理论 | 8篇 |
预防医学 | 1448篇 |
眼科学 | 756篇 |
药学 | 846篇 |
中国医学 | 12篇 |
肿瘤学 | 1245篇 |
出版年
2023年 | 263篇 |
2021年 | 235篇 |
2020年 | 172篇 |
2019年 | 223篇 |
2018年 | 434篇 |
2017年 | 414篇 |
2016年 | 410篇 |
2015年 | 452篇 |
2014年 | 586篇 |
2013年 | 735篇 |
2012年 | 889篇 |
2011年 | 841篇 |
2010年 | 633篇 |
2009年 | 581篇 |
2008年 | 801篇 |
2007年 | 899篇 |
2006年 | 868篇 |
2005年 | 729篇 |
2004年 | 771篇 |
2003年 | 760篇 |
2002年 | 754篇 |
2001年 | 462篇 |
2000年 | 460篇 |
1999年 | 420篇 |
1998年 | 233篇 |
1997年 | 222篇 |
1996年 | 226篇 |
1995年 | 213篇 |
1994年 | 210篇 |
1993年 | 163篇 |
1992年 | 381篇 |
1991年 | 326篇 |
1990年 | 313篇 |
1989年 | 313篇 |
1988年 | 279篇 |
1987年 | 242篇 |
1986年 | 278篇 |
1985年 | 321篇 |
1984年 | 269篇 |
1983年 | 182篇 |
1982年 | 140篇 |
1981年 | 134篇 |
1980年 | 109篇 |
1979年 | 181篇 |
1978年 | 124篇 |
1977年 | 121篇 |
1976年 | 112篇 |
1975年 | 97篇 |
1974年 | 118篇 |
1972年 | 114篇 |
排序方式: 共有10000条查询结果,搜索用时 625 毫秒
111.
Marilyn Rodney Carla Clasen Gloria Goldman Ronald Markert Donna Deane 《Journal of community health》1998,23(5):371-381
The title Community Health Advocate (CHA) is one of thirty or more titles used throughout the world for an indigenous outreach worker who is trusted and respected in his or her community and who serves as a bridge between peers and health professionals. In 1992, the Center for Healthy Communities in Dayton, Ohio developed a program to train as Advocates people indigenous to the communities in which they would be working. Since the first CHAs began work in January 1993, the effectiveness of the program has been evaluated from three perspectives: the Community Health Advocates, the managers directors of the community sites at which the CHAs work, and the clients with whom the CHAs work. Advocates indicated that the training program adequately prepared them for their roles and functions. They also identified systematic frustrations and barriers that made it more difficult for them to perform their job. Community site directors and community leaders indicated that the CHAs were considered a positive force in meeting client needs and facilitating independence, and were very effective in outreach and coordination of resources. A survey of CHA clients revealed an overwhelmingly positive response to the Advocate's work, validating the belief that CHAs can fill an important niche in the health care community. The three evaluation processes described in this paper helped to document the need for and the effectiveness of this program and can serve as a model for similar programs. 相似文献
112.
Inactivation of human synovial fluid phospholipase A2 by the marine natural product, manoalide 总被引:2,自引:0,他引:2
The marine natural product, manoalide (MLD), was investigated to determine if this drug inhibited purified human synovial fluid phospholipase A2 (HSF-PLA2). Utilizing classical Michaelis-Menten kinetics, apparent Km and Vmax values for HSF-PLA2 of 1.34 mM and 0.47 mumol [3H]palmitic acid released/min/mg protein were obtained using dipalmitoylphosphatidylcholine (DPPC) as the substrate, and 38.0 microM and 18.8 mumol [3H]arachidonic acid released/min/mg protein with Escherichia coli as a natural substrate. These kinetic parameters were utilized subsequently to evaluate the inhibitory effects of manoalide on HSF-PLA2. Inhibition of HSF-PLA2 by MLD was concentration and time dependent with IC50 values of 0.2 and 0.02 microM for DPPC and E. coli respectively. Dialysis studies and examination of DPPC or E. coli hydrolysis versus enzyme concentration indicate that MLD is an irreversible inhibitor of HSF-PLA2. Substrate specificity was also examined in the absence and presence of MLD using dipalmitoylphosphatidylethanolamine (DPPE) as a substrate. MLD inhibited the hydrolysis of DPPE (greater than 90% inhibition at 2 microM), and preliminary results indicate that DPPC was more readily hydrolyzed than DPPE under the substrate conditions of the assay. While the cellular source of secreted HSF-PLA2 is unknown, these studies indicate that MLD can inactivate secreted phospholipase A2 isolated from patients with inflammatory joint disease. 相似文献
113.
W. Jacobs 《Der Onkologe》2005,11(3):279-284
Zusammenfassung Versorgungsstrukturen und Versorgungsqualität zu analysieren, sie zu steuern und zu optimieren, gehört mittlerweile zum Kerngeschäft der gesetzlichen Krankenversicherungen (GKV). Ziele von Veränderungen sind mehr Qualität und höhere Effizienz zum Nutzen der Patienten, aber auch aus ökonomischen Gründen. Am Beispiel der Veränderung der Versorgung von Mammakarzinompatientinnen wird die Rolle der Krankenkassen exemplarisch dargestellt. Nach Analyse der Ausgangssituation, die Handlungsbedarf sowohl hinsichtlich der Versorgungsqualität als auch der Patientinnenzufriedenheit ergab, wurde ein Disease-Management-Programm (DMP) Brustkrebs eingeführt, das den ambulanten und stationären Bereich vernetzt und einen Zentrierungsprozess zur Folge hatte. Wesentliche Ziele des DMP Brustkrebs sind: Verbesserung der Qualität des gesamten Behandlungsprozesses durch Zentrierung, Leitlinien- und Evidenzbasierung und starke Vernetzung des ambulanten und stationären Bereichs, Verbesserung der Information und Begleitung der an Brustkrebs erkrankten Frauen und stärkere Mitwirkung der Patientin bei Entscheidungen über die Therapieschritte. 相似文献
114.
W. Jacobs 《Der Onkologe》2005,12(1):279-284
Versorgungsstrukturen und Versorgungsqualität zu analysieren, sie zu steuern und zu optimieren, gehört mittlerweile zum Kerngeschäft der gesetzlichen Krankenversicherungen (GKV). Ziele von Veränderungen sind mehr Qualität und höhere Effizienz zum Nutzen der Patienten, aber auch aus ökonomischen Gründen. Am Beispiel der Veränderung der Versorgung von Mammakarzinompatientinnen wird die Rolle der Krankenkassen exemplarisch dargestellt. Nach Analyse der Ausgangssituation, die Handlungsbedarf sowohl hinsichtlich der Versorgungsqualität als auch der Patientinnenzufriedenheit ergab, wurde ein Disease-Management-Programm (DMP) Brustkrebs eingeführt, das den ambulanten und stationären Bereich vernetzt und einen Zentrierungsprozess zur Folge hatte. Wesentliche Ziele des DMP Brustkrebs sind: Verbesserung der Qualität des gesamten Behandlungsprozesses durch Zentrierung, Leitlinien- und Evidenzbasierung und starke Vernetzung des ambulanten und stationären Bereichs, Verbesserung der Information und Begleitung der an Brustkrebs erkrankten Frauen und stärkere Mitwirkung der Patientin bei Entscheidungen über die Therapieschritte. 相似文献
115.
Adhesion molecules play an important role in inflammatory and immunological responses. We assessed the expression pattern
of intercellular adhesion molecule-1 (ICAM-1) and lymphocytefunction-associated antigen-1 (LFA-1) in the livers of mice experimentally
infected with Schistosoma mansoni and in synchronous hepatic granulomas induced by injection of soluble egg antigen (SEA)-coupled Sepharose beads in a mesenteric
vein of mice. By immunohistochemistry, confocal laser scanning microscopy, and immunoelectron microscopy, ICAM-1 was localized
on endothelial cells, sinusoidal-lining cells (Kupffer cells and sinusoidal endothelium), the hepatocyte cell membrane facing
Disse's space, and inflammatory cells in the granuloma. LFA-1 was visualized on the inflammatory cells of the granuloma and
on phagocytic sinusoidal-lining cells, most likely Kupffer cells. ICAM-1- and LFA-1-immunoreactive cells were present in the
granuloma as early as at 3 days after injection of SEA-coupled beads and persisted with time. As granulomas became older,
nonimmunoreactive granuloma cells appeared. We conclude that adhesion molecules play an important role in the genesis of the
schistosomal granuloma.
Received: 16 September 1996 / Accepted: 24 October 1996 相似文献
116.
Macromastia in adolescence 总被引:3,自引:0,他引:3
Macromastia is a deforming, disabling, and painful condition, especially in the adolescent. Multiple procedures have been advocated and are successful for the reduction of breast tissue. In addition, adjunctive therapy with hormones may prevent relapse. The hormonal influences on breast development and the etiology of macromastia remain complex and not well understood. It is safe to surmise that the pathologic condition is multifactorial, with both inherited and acquired aspects. In the various techniques for reduction, it is important to have a clear understanding of vascular and neural innervation of the breast in order to maintain maximum security in reduction without loss of excessive vital tissue. Although both sensory ability and lactation function are diminished with most procedures and eliminated with some, careful planning and patient counseling in all cases should lead to maximal benefit and optimal results. 相似文献
117.
118.
119.
120.
Sinonasal surfactant protein A1, A2, and D gene expression in cystic fibrosis: a preliminary report. 总被引:1,自引:0,他引:1
Bradford A Woodworth Rachel Wood John E Baatz Rodney J Schlosser 《Otolaryngology--head and neck surgery》2007,137(1):34-38
OBJECTIVE: To measure alterations in SPA1, A2, and D gene expression in various forms of inflammatory chronic rhinosinusitis (CRS). STUDY DESIGN AND SETTING: Sinus mucosal biopsies were performed in patients with allergic fungal rhinosinusitis (AFS), CRS with nasal polyposis, cystic fibrosis (CF), and controls. SP mRNA was measured with quantitative polymerase chain reaction. RESULTS: Patients with CF (n = 4) showed significantly increased SPA1 (82-fold), SPA2 (100-fold), and SPD (47-fold) mRNA (P < 0.05) when compared with controls (n = 5). Patients with CRS with nasal polyposis (n = 5) also demonstrated elevated SPA1 (27-fold), SPA2 (13-fold), and SPD (13-fold). Patients with AFS (n = 7) had increased SPA1 (5-fold), SPA2 (9-fold), and SPD (17-fold), but were not statistically significant. CONCLUSION: SPA1, A2, and D are upregulated in various forms of CRS, but are significantly elevated in cystic fibrosis CRS. SIGNIFICANCE: Understanding the role of SPs in CRS will help develop novel treatment approaches for sinonasal pathoses. 相似文献